FDA Drug recall D-1047-2016
Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix P…
- FDA Drug
- Class III
- terminated
- Published 2016-06-29
On 2016-06-29 the FDA classified a Class III recall of Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix P… by Attix Pharmaceuticals, citing cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1047-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-05-18 |
| Published | 2016-06-29 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Attix Pharmaceuticals |
| Distribution | CO |
Product
Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada
Reason
cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
Identifiers
| code_info | Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1047-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.